A merger announced with fanfare just months ago is dead. One You DNA, the supposed union of Uforia Science and MaVie, has quietly vanished. In its place, MaVie has now merged with Ariix, a move that raises hard questions about what went wrong and why founder Abboud Barakat was forced to shop his company around.

The collapse happened fast. Back in late February, Uforia Science and MaVie announced they were merging into One You DNA. By the time word got out about the Ariix deal, One You DNA's website was already offline and unresponsive.

Under the new arrangement, MaVie representatives will move into Ariix's compensation structure, transitioning to what Ariix calls its patent-pending ACTIV8 Compensation Plan. They'll gain access to Ariix's full product catalog across all its registered markets. The companies say they'll operate normally during the transition, with details on product availability to come later.

But the timing screams trouble. When MaVie and Uforia announced their merger in February, Barakat promised big things. "We feel strongly that joining forces will allow us to realize our strategic goals as we aspire to be the next billion-dollar company," he said then.

Now that language has softened considerably. The Ariix partnership, Barakat said, "provides the ideal environment for significant growth" and praised Ariix's "ethical and value-driven business model — a model that is very difficult to find today." Whether that last line was a subtle jab at Uforia Science remains unclear.

The Ariix connection isn't new. Barakat has maintained a close relationship with the company since MaVie launched. That relationship came under scrutiny two years ago when WorldVentures sued MaVie, alleging that Barakat had stolen its confidential information to benefit both Ariix and MaVie's launch. The lawsuit settled in December 2019, but the terms were kept secret.

The sequence of events points to a company in distress. Barakat went from pitching a billion-dollar vision with Uforia Science to abandoning that merger entirely within months. Now he's merged MaVie into a company with which he had prior ties—a common move for founders trying to salvage operations that have lost momentum.

The real questions remain unanswered. What specifically killed the One You DNA deal? Was it poor sales performance, internal conflict, or something else entirely? And what does it say about MaVie's financial state that Barakat needed a buyer at all?

The answers may never come public. In the world of network marketing, failed mergers and quiet restructurings rarely get explained in detail. Investors and representatives are simply told to move forward. The One You DNA website going dark suggests this transition was more urgent than the companies' measured language suggests.

🤖 Quick Answer

What happened to the One You DNA merger?
One You DNA, the merger between Uforia Science and MaVie announced in February, collapsed shortly after its announcement. MaVie subsequently merged with Ariix instead, with One You DNA's website going offline as the transition occurred.

Why did MaVie shift from One You DNA to Ariix?
The specific reasons for One You DNA's failure remain unclear. However, the rapid collapse forced founder Abboud Barakat to pursue alternative partnerships, ultimately leading to MaVie's merger with Ariix and integration into its ACTIV8 Compensation Plan.

What changes occurred for MaVie representatives under the Ariix merger?
MaVie representatives transitioned into Ariix's compensation structure through the patent-pending ACTIV8 Compensation Plan. Representatives gained access to Ariix's complete product catalog across

🔗 Related Articles

- $260,575 worth of weed found in Herbalife meal shake tins
- Ash Mufareh declares “only God can stop OnPassive!”
- WMI’s advertising standards: Why the iron grip?
- Cloud Token collapse due to hackers, COVID-19 & authorities
- 10xBitcoin Review: Seven-tier 2×15 matrix pyramid recruitment